These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15642671)

  • 1. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
    Ogmundsdóttir HM; Haraldsdóttirm V; Jóhannesson GM; Olafsdóttir G; Bjarnadóttir K; Sigvaldason H; Tulinius H
    Haematologica; 2005 Jan; 90(1):66-71. PubMed ID: 15642671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
    Landgren O; Linet MS; McMaster ML; Gridley G; Hemminki K; Goldin LR
    Int J Cancer; 2006 Jun; 118(12):3095-8. PubMed ID: 16395700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members.
    Steingrímsdóttir H; Einarsdóttir HK; Haraldsdóttir V; Ogmundsdóttir HM
    Eur J Haematol; 2011 May; 86(5):396-404. PubMed ID: 21342269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.
    Amundadottir LT; Thorvaldsson S; Gudbjartsson DF; Sulem P; Kristjansson K; Arnason S; Gulcher JR; Bjornsson J; Kong A; Thorsteinsdottir U; Stefansson K
    PLoS Med; 2004 Dec; 1(3):e65. PubMed ID: 15630470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
    Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cancer among relatives of patients with glioma.
    O'Neill BP; Blondal H; Yang P; Olafsdottir GH; Sigvaldason H; Jenkins RB; Kimmel DW; Scheithauer BW; Rocca WA; Bjornsson J; Tulinius H
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):921-4. PubMed ID: 12223439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
    Martín P; Santón A; García-Cosío M; Bellas C
    Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity in multiple myeloma families.
    Lynch HT; Watson P; Tarantolo S; Wiernik PH; Quinn-Laquer B; Isgur Bergsagel K; Huiart L; Olopade OI; Sobol H; Sanger W; Hogg D; Weisenburger D
    J Clin Oncol; 2005 Feb; 23(4):685-93. PubMed ID: 15681516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West].
    Schaar CG; Ong F; Snijder S; Wijermans PW; Franck PF; Kluin-Nelemans JC
    Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1591-5. PubMed ID: 9763839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.
    Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Ekbom A; Askling J
    Gastroenterology; 2009 Oct; 137(4):1301-9. PubMed ID: 19622361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture risk in patients with monoclonal gammopathy of undetermined significance.
    Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M
    Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Int J Cancer; 2009 Nov; 125(9):2147-50. PubMed ID: 19582882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial report of a family registry of multiple myeloma.
    Coleman EA; Lynch H; Enderlin C; Stewart B; Thomé SD; Kennedy R; Richardson-Nelson T; Barlogie B
    Cancer Nurs; 2009; 32(6):456-64. PubMed ID: 19816167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
    Nielsen NM; Frisch M; Rostgaard K; Wohlfahrt J; Hjalgrim H; Koch-Henriksen N; Melbye M; Westergaard T
    Mult Scler; 2008 Jul; 14(6):823-9. PubMed ID: 18573841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
    Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B
    Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
    Eldon BJ; Thorlacius S; Jonsson T; Jonasson JG; Kjartansson J; Bodvarsson S; Steingrimsson E; Rafnar T
    Eur J Cancer; 2006 May; 42(7):922-6. PubMed ID: 16530404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
    Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.